Aurinia Pharmaceuticals Inc. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Aurinia Pharmaceuticals Inc. on November 13, 2019. The filing serves to incorporate a news release regarding updates to the Company's Board of Directors by reference into the Company's Registration Statement on Form F-10 (File No. 333-222413).
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a corporate governance update and does not contain financial statements or performance data.
Material Changes
The material change disclosed in this filing is an update to the composition of the Board of Directors, as detailed in the incorporated news release (Exhibit 99.1). No financial material changes are reported in this document.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. The document is limited to the announcement of board changes.
Key Facts for Investor Verification
- Verify the specific details of the Board of Directors updates referenced in Exhibit 99.1.
- Confirm the status of the Registration Statement on Form F-10 (File No. 333-222413) into which this report is incorporated.
- Note that this filing contains no financial performance data for the period.